porozendoОстеопороз и остеопатииOsteoporosis and Bone Diseases2072-26802311-0716Endocrinology Research Centre10.14341/osteo201617-8porozendo-8927Research ArticleСтатьиArticlesМИКРОРНК: ОТ БИОЛОГИИ К КЛИНИЧЕСКОМУ ПРИМЕНЕНИЮMICRORNAS: FROM BIOLOGY TO CLINICAL IMPLEMENTATIONNonnLarisaNonnLarisa
PH.D. Department of Pathology
-University of Illinois at Chicago201615122016191№1 (2016)78Copyright © Nonn L., 20162016Nonn L.Nonn L.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.osteo-endojournals.ru/jour/article/view/8927ReferencesAmbros V. The functions of animal microRNAs. Nature. 2004 Sep 16;431(7006):350-5. PubMed PMID: 15372042.Ambros V. The functions of animal microRNAs. Nature. 2004 Sep 16;431(7006):350-5. PubMed PMID: 15372042.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215-33. PubMed PMID: 19167326. Pubmed Central PMCID: 3794896.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136(2):215-33. PubMed PMID: 19167326. Pubmed Central PMCID: 3794896.Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008 Oct 23;455(7216):1124-8. PubMed PMID: 18806776.Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008 Oct 23;455(7216):1124-8. PubMed PMID: 18806776.Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007 Dec 21;318(5858):1931-4. PubMed PMID: 18048652.Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007 Dec 21;318(5858):1931-4. PubMed PMID: 18048652.Huang V, Zheng J, Qi Z, Wang J, Place RF, Yu J, et al. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS genetics. 2013;9(9):e1003821. PubMed PMID: 24086155. Pubmed Central PMCID: 3784563.Huang V, Zheng J, Qi Z, Wang J, Place RF, Yu J, et al. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS genetics. 2013;9(9):e1003821. PubMed PMID: 24086155. Pubmed Central PMCID: 3784563.Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences of the United States of America. 2008 Feb 5; 105(5): 1608-13. PubMed PMID: 18227514. Pubmed Central PMCID: 2234192.Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences of the United States of America. 2008 Feb 5; 105(5): 1608-13. PubMed PMID: 18227514. Pubmed Central PMCID: 2234192.Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America. 2008 Jul 29;105(30): 10513-8. PubMed PMID: 18663219. Pubmed Central PMCID: 2492472.Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America. 2008 Jul 29;105(30): 10513-8. PubMed PMID: 18663219. Pubmed Central PMCID: 2492472.Nonn L, Vaishnav A, Gallagher L, Gann PH. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Experimental and molecular pathology. 2010 Feb;88(1):45-51. PubMed PMID: 19874819. Pubmed Central PMCID: 2815196.Nonn L, Vaishnav A, Gallagher L, Gann PH. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Experimental and molecular pathology. 2010 Feb;88(1):45-51. PubMed PMID: 19874819. Pubmed Central PMCID: 2815196.Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. The oncologist. 2012;17(6):801-12. PubMed PMID: 22618571. Pubmed Central PMCID: 3380879.Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. The oncologist. 2012;17(6):801-12. PubMed PMID: 22618571. Pubmed Central PMCID: 3380879.Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000Research. 2013;2:136. PubMed PMID: 24627783. Pubmed Central PMCID: 3917658.Hydbring P, Badalian-Very G. Clinical applications of microRNAs. F1000Research. 2013;2:136. PubMed PMID: 24627783. Pubmed Central PMCID: 3917658.Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. The New England journal of medicine. 2013 May 2;368(18):1685-94. PubMed PMID: 23534542.Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. The New England journal of medicine. 2013 May 2;368(18):1685-94. PubMed PMID: 23534542.Giangreco AA, Vaishnav A, Wagner D, Finelli A, Fleshner N, Van der Kwast T, et al. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Cancer prevention research. 2013 May;6(5):483-94. PubMed PMID: 23503652. Pubmed Central PMCID: 3644314.Giangreco AA, Vaishnav A, Wagner D, Finelli A, Fleshner N, Van der Kwast T, et al. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue. Cancer prevention research. 2013 May;6(5):483-94. PubMed PMID: 23503652. Pubmed Central PMCID: 3644314.Mihelich BL, Maranville JC, Nolley R, Peehl DM, Nonn L. Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort. PloS one. 2015;10(4):e0124245. PubMed PMID: 25874774. Pubmed Central PMCID: 4396984.Mihelich BL, Maranville JC, Nolley R, Peehl DM, Nonn L. Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort. PloS one. 2015;10(4):e0124245. PubMed PMID: 25874774. Pubmed Central PMCID: 4396984.
The authors declare that there are no conflicts of interest present.